| Shareholder | |||
|---|---|---|---|
| WuXi Biologics (Cayman) Inc. | 60.67% | 468.85M | |
| Center Laboratories, Inc. | 28.59% | 220.96M | |
| Vivo Capital VIII, LLC | 18.11% | 103.25M | |
| Suzhou Vivo Management Consulting Partnership (Limited Partnership) | 15.19% | 116.25M | |
| Pang Kee Chan Hebert | 8.62% | 49.14M | |
| Tricor Trust (Hong Kong) Limited | 5.05% | 38.99M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of BIODLINK-B (01875) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

